(Q44784244)

6 December 2017

title

Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients (English)

1 reference

6 December 2017

0 references

1

1 reference

6 December 2017

Kjell Erlandsson

2

1 reference

6 December 2017

Edgar P Spencer

series ordinal

3

1 reference

6 December 2017

Peter J Ell

series ordinal

4

1 reference

6 December 2017

Lyn S Pilowsky

series ordinal

5

1 reference

6 December 2017

publication date

1 September 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

175

1 reference

6 December 2017

issue

3

1 reference

6 December 2017

page(s)

367-373

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-1826-6

6 December 2017

exact match

0 references

cites work

Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses

1 reference

12 December 2020

Serum prolactin and clinical state during neuroleptic treatment and withdrawal

1 reference

12 December 2020

Long-term effects of neuroleptic drugs on the neuroendocrine system

1 reference

12 December 2020

In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia.

1 reference

12 December 2020

In vivo extrastriatal and striatal D2 dopamine receptor blockade by amisulpride in schizophrenia

1 reference

12 December 2020

Dopamine receptors and brain function.

1 reference

12 December 2020

Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients

1 reference

12 December 2020

A rating scale for drug-induced akathisia

1 reference

12 December 2020

Tolerance to prolactin secretion in the long-term treatment with neuroleptics in schizophrenia.

1 reference

12 December 2020

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

1 reference

12 December 2020

The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration

1 reference

12 December 2020

The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients

1 reference

12 December 2020

Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.

1 reference

12 December 2020

Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance?

1 reference

12 December 2020

Tolerance to the prolactin-elevating effect of neuroleptics

1 reference

12 December 2020

Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findings

1 reference

12 December 2020

Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay.

1 reference

12 December 2020

1 reference

12 December 2020

Comparison of methods for analysis of clinical [11C]raclopride studies.

1 reference

12 December 2020

Simplified reference tissue model for PET receptor studies.

1 reference

12 December 2020

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

Neuroendocrine effects of chronic administration of sodium valproate in epileptic patients

1 reference

12 December 2020

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

Partial characterization of a neurotransmitter pathway regulating the in vivo release of prolactin

1 reference

12 December 2020

The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats

1 reference

12 December 2020

Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups

1 reference

12 December 2020

A study of serum prolactin levels in schizophrenia: comparison of males and females

1 reference

12 December 2020

Reliability and validity of a depression rating scale for schizophrenics

1 reference

12 December 2020

Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients

1 reference

12 December 2020

A rating scale for extrapyramidal side effects

1 reference

12 December 2020

Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study

1 reference

12 December 2020

Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels

1 reference

12 December 2020

Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients

1 reference

12 December 2020

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

12 December 2020

Neuroendocrine response to antipsychotics: effects of drug type and gender.

1 reference

12 December 2020

10.1007/S00213-004-1826-6

Identifiers

DOI

1 reference

6 December 2017

1 reference